Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Presents New Research Results Concerning KAND567

Sept 3 (Reuters) - Kancera AB  KANC.ST :
    * PRESENTS NEW RESEARCH RESULTS CONCERNING KAND567
    * EXPECTS TO REPORT RESULTS FROM PHASE IB STUDY IN DECEMBER

Source text for Eikon:  ID:nWkr17QNkJ 
Further company coverage:  KANC.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Novakand Pharma AB

See all news